Skip to main content

Procalcitonin as a Marker of Etiology in Adults Hospitalized with Community-Acquired Pneumonia.


AUTHORS

Self WH , Balk RA , Grijalva CG , Williams DJ , Zhu Y , Anderson EJ , Waterer GW , Courtney DM , Bramley AM , Trabue C , Fakhran S , Blaschke AJ , Jain S , Edwards KM , Wunderink RG , . Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017 4 12; ().

ABSTRACT

Recent trials suggest procalcitonin-based guidelines can reduce antibiotic use for respiratory infections. However, the accuracy of procalcitonin to discriminate between viral and bacterial pneumonia requires further dissection.


Recent trials suggest procalcitonin-based guidelines can reduce antibiotic use for respiratory infections. However, the accuracy of procalcitonin to discriminate between viral and bacterial pneumonia requires further dissection.


Tags: